---

Acute phase reactants in hemodialysis patients in relation to ejection fraction

---

Original Article

Author Details : Ruksana Kausar, Syyeda Anees*, Shaikh Mahmood, Abbas M Hyder

Volume : 7, Issue : 4, Year : 2020

Article Page : 484-487

https://doi.org/10.18231/j.ijcbr.2020.102

Suggest article by email

Get Permission

---

Abstract

Chronic Kidney Disease (CKD) is considered a public health problem because of its high prevalence, morbidity and mortality. 1 Morbidity remains high with more than 20% of patients undergoing hemodialysis dying every year with frequent complications of heart disease, hypertension, anaemia, inflammation and physical function. 2 Coronary artery disease has accounted for 40-50% of deaths among patients who undergo dialysis. Myocardial infarction has approximately accounted for 10-20% of these deaths which occur shortly after initiating dialysis with 29% within 1 year and 52% within 2 years. The risk increases as the kidney function declines. The present study aims to study the serum levels of hs-CRP and ferritin in hemodialysis patients and to
correlate with ejection fraction as an indirect association of coronary artery disease and therefore to study the role of inflammatory markers hs-CRP and ferritin in hemodialysis patients and their role as predictive markers in coronary artery disease.
The study included 50 hemodialysis patients with CAD and 50 hemodialysis patients without CAD. hs-CRP and ferritin parameters were analysed. hs-CRP and ferritin levels were significantly increased in hemodialysis patients with CAD (p<0>

Keywords: hs-CRP, Ferritin, Hemodialysis, Coronary artery disease, Ejection fraction.

How to cite : Kausar R , Anees S , Mahmood S , Hyder A M , Acute phase reactants in hemodialysis patients in relation to ejection fraction. Int J Clin Biochem Res 2020;7(4):484-487

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.